Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
about
sameAs
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansMULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathwayPerlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesisEndorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonismEndorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cellsThe first draft of the endostatin interaction networkRibozyme-mediated perlecan knockdown impairs chondrogenic differentiation of C3H10T1/2 fibroblasts.Developmental and pathogenic mechanisms of basement membrane assemblyA central function for perlecan in skeletal muscle and cardiovascular developmentProteoglycans in liver cancerHeparan Sulfate Proteoglycans May Promote or Inhibit Cancer Progression by Interacting with Integrins and Affecting Cell MigrationThe role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagyDecoding the Matrix: Instructive Roles of Proteoglycan ReceptorsCan we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrixVascular proteomics in metabolic and cardiovascular diseasesExtracellular Matrix, a Hard Player in AngiogenesisPivotal role for decorin in angiogenesisEssential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesisA fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activityA current view of perlecan in physiology and pathology: A mosaic of functions.A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis.Opticin exerts its anti-angiogenic activity by regulating extracellular matrix adhesivenessAssociation of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.A novel interaction between perlecan protein core and progranulin: potential effects on tumor growth.The Drosophila Perlecan gene trol regulates multiple signaling pathways in different developmental contexts.Endorepellin evokes autophagy in endothelial cellsExtracellular matrix modulates angiogenesis in physiological and pathological conditions.Urinary proteomic analysis of chronic allograft nephropathy.Microvascular rarefaction: the decline and fall of blood vesselsMatrix regulators in neural stem cell functions.Parstatin, a novel protease-activated receptor 1-derived inhibitor of angiogenesis.Type IIB procollagen NH(2)-propeptide induces death of tumor cells via interaction with integrins alpha(V)beta(3) and alpha(V)beta(5).Matrix metalloproteinase control of capillary morphogenesis.Perlecan Domain V induces VEGf secretion in brain endothelial cells through integrin α5β1 and ERK-dependent signaling pathways.LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.Perlecan maintains microvessel integrity in vivo and modulates their formation in vitroSortilin regulates progranulin action in castration-resistant prostate cancer cellsOsteoblastic cell secretome: a novel role for progranulin during risedronate treatment
P2860
Q21710680-AFD6F898-32F3-4422-B058-64ABBE5F6747Q24294441-F64A5D84-3A15-4173-BC9B-A174F870A1E0Q24295251-027ABDB1-55BC-4BD2-915B-687F1318D377Q24303934-3BBB60A2-8950-48D5-A6BC-22E25B3ED020Q24312922-6AE20DD6-877D-4F7D-A088-60DBFCD90CE0Q24338820-4604E0EF-9834-4FF1-A867-26FCD2F50B26Q24540423-A73F346D-E181-4E20-87FA-25B50F55C22EQ24608109-B2B02304-BDD5-45A4-9E03-6D8961E96916Q24648227-019A5FF5-ADE4-42F2-8CB7-34511FA6DBA6Q26772304-4D2B1816-3218-4B6A-8F96-CE731EC8DCECQ26777586-86B4E015-35AB-4AE5-87EF-AA19082F6A11Q26800258-235ED535-6D8B-4C9A-9661-56FD76C224F9Q26801397-EEF80C69-C9BE-4367-9C75-C2A5F181D18CQ27021503-86D28A30-91DE-4B19-9FFB-AD6A2EB239DBQ28066160-526F20B0-8523-4B8E-A9E2-17A49AAB84DCQ28070315-EBB98B34-2876-4FAC-A04A-C706C21120EBQ28072886-AFAD334C-951D-47D1-8604-C89872BC0BAFQ28085303-A843B98B-6E1A-409C-97EC-94069371B981Q28294512-464AE835-2291-49D1-B1D8-2035D7AB3521Q28730956-17577846-4E6D-42CB-8ABE-EDED5752CC80Q30392738-4F6AD52F-7909-44A6-94B3-6C1597212B5BQ30489730-B2F3B1D1-E815-46FA-BA4F-DBA46AC0AB63Q30524624-89F300B9-77C3-41AE-99DF-17982F7E291CQ31115552-84C25AE3-2AF5-4A63-9A62-7A9F03ED729FQ33112683-F3D52683-84C4-482F-886F-D2F49ED5C97EQ33292070-A9AE6E27-9D70-4EA0-A911-43BE3251745CQ33304884-361AD250-068C-4666-9FC0-4AAD43F727A8Q33718473-4C092187-0AEC-42F4-9763-E0F4353ED163Q33737210-DA13438F-773B-47EE-9564-A8369A71F574Q33764407-BA4D3AAE-E407-4961-8325-5176D2C90E8DQ33818980-A3557CA5-BC67-414D-A5B2-B97631CBECCFQ33819268-5D78424B-036C-4E5D-AF16-1F07B3CE57D1Q33824563-0073A75A-DB4E-4759-8385-C12BEB053C08Q33967052-009C7FBC-5318-45BF-93FF-C7ECD6A01002Q34002149-5691C83D-C8ED-4665-8CEA-9372F1F661D5Q34428518-8B6D05A5-0D75-4A96-9421-60C4FF0BD917Q34480669-899F9ED1-4A07-445A-8396-CC8237E39327Q34548326-ACDB0B9B-7E7C-4B54-9FBA-48E9AD3594FDQ34745270-1A8FF3B0-76A8-4CF1-B941-814F5382E16BQ35016295-8C80E0A6-C3B9-4785-B18A-C53C02331F53
P2860
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@ast
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@en
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@nl
type
label
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@ast
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@en
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@nl
prefLabel
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@ast
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@en
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@nl
P2093
P3181
P356
P1476
Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
@en
P2093
James D San Antonio
Shawn M Sweeney
P304
P3181
P356
10.1074/JBC.M210445200
P407
P577
2002-11-14T00:00:00Z